This column is provided by ONU HeathWise Pharmacy.
The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for a third combination test for COVID-19 and the flu.
This new test is found under the name Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay.
The FDA previously issued EUAs to BioFire Diagnostics LLC and QIAGEN GmbH for their combination tests. These particular combination tests can help identify other respiratory organisms in addition to the viruses that cause the flu and COVID-19.
